Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mignot

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Experimental Neurology|June 6, 1998
Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic caninesM S Reid, S Nishino, M Tafti, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleepS Nishino, L Haak, H Shepherd, et al.
Sleep|April 1, 1994
Stability of cataplexy over several months--information for the design of therapeutic trialsM Gelb, C Guilleminault, H Kraemer, et al.
Neurology|November 26, 2003
CSF hypocretin-1 levels in restless legs syndromeK Stiasny-Kolster, E Mignot, L Ling, et al.
Sleep|October 1, 1992
Serum prolactin response to a D2 antagonist in narcoleptic and control caninesS Nishino, J Arrigoni, L H Sharp, et al.
Neurology|January 14, 2004
Hypocretin-1 CSF levels in anti-Ma2 associated encephalitisS Overeem, J Dalmau, L Bataller, et al.
Brain, Behavior, and Immunity|May 26, 2004
Exploring the cytokine and endocrine involvement in narcolepsyM L Okun, S Giese, L Lin, et al.
Human Immunology|March 1, 1995
Extensive polymorphism of a (CA)n microsatellite located in the HLA-DQA1/DQB1 class II regionC Macaubas, J Hallmayer, J Kalil, et al.
Sleep|December 1, 1993
A novel HLA DR17,DQ1 (DQA1-0102/DQB1-0602 positive) haplotype predisposing to narcolepsy in CaucasiansE Mignot, X Lin, P E Hesla, et al.
The European Journal of Neuroscience|October 31, 2001
Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activitiesY Yoshida, N Fujiki, T Nakajima, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Experimental Neurology|June 6, 1998
Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic caninesM S Reid, S Nishino, M Tafti, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleepS Nishino, L Haak, H Shepherd, et al.
Sleep|April 1, 1994
Stability of cataplexy over several months--information for the design of therapeutic trialsM Gelb, C Guilleminault, H Kraemer, et al.
Neurology|November 26, 2003
CSF hypocretin-1 levels in restless legs syndromeK Stiasny-Kolster, E Mignot, L Ling, et al.
Sleep|October 1, 1992
Serum prolactin response to a D2 antagonist in narcoleptic and control caninesS Nishino, J Arrigoni, L H Sharp, et al.
Neurology|January 14, 2004
Hypocretin-1 CSF levels in anti-Ma2 associated encephalitisS Overeem, J Dalmau, L Bataller, et al.
Brain, Behavior, and Immunity|May 26, 2004
Exploring the cytokine and endocrine involvement in narcolepsyM L Okun, S Giese, L Lin, et al.
Human Immunology|March 1, 1995
Extensive polymorphism of a (CA)n microsatellite located in the HLA-DQA1/DQB1 class II regionC Macaubas, J Hallmayer, J Kalil, et al.
Sleep|December 1, 1993
A novel HLA DR17,DQ1 (DQA1-0102/DQB1-0602 positive) haplotype predisposing to narcolepsy in CaucasiansE Mignot, X Lin, P E Hesla, et al.
The European Journal of Neuroscience|October 31, 2001
Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activitiesY Yoshida, N Fujiki, T Nakajima, et al.
Pageof 17